Compare FRT & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRT | BIO |
|---|---|---|
| Founded | 1962 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 10.1B |
| IPO Year | 1994 | 1994 |
| Metric | FRT | BIO |
|---|---|---|
| Price | $110.44 | $378.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 4 |
| Target Price | $112.08 | ★ $339.75 |
| AVG Volume (30 Days) | ★ 710.2K | 243.5K |
| Earning Date | 05-01-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.09% | N/A |
| EPS Growth | 36.84 | ★ 142.61 |
| EPS | ★ 1.81 | N/A |
| Revenue | $1,278,975,000.00 | ★ $2,583,200,000.00 |
| Revenue This Year | $6.10 | $2.74 |
| Revenue Next Year | $4.64 | $3.20 |
| P/E Ratio | $60.97 | ★ N/A |
| Revenue Growth | ★ 6.36 | 0.65 |
| 52 Week Low | $90.03 | $236.73 |
| 52 Week High | $128.21 | $396.23 |
| Indicator | FRT | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 28.08 | 55.40 |
| Support Level | $103.41 | $364.41 |
| Resistance Level | $110.89 | $396.23 |
| Average True Range (ATR) | 1.68 | 9.50 |
| MACD | -0.25 | -1.39 |
| Stochastic Oscillator | 15.04 | 57.47 |
Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 103 properties, which includes 28.8 million square feet of retail space and 2,500 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.